Vir Biotechnology, Inc.
VIR
$10.81
-$0.37-3.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 163.71% | -192.84% | 73.69% | -47.03% | 8.27% |
| Total Depreciation and Amortization | -0.32% | -3.00% | -3.34% | 2.78% | 1.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.79% | -22.43% | 28.99% | 2.26% | -7.47% |
| Change in Net Operating Assets | 203.46% | -697.57% | 86.19% | 17.80% | -196.17% |
| Cash from Operations | 193.16% | -411.62% | 84.56% | -39.39% | -53.90% |
| Capital Expenditure | 91.79% | -12.07% | -9.78% | 87.51% | -55.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -397.30% | -17.78% | -83.99% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,712.35% | -85.97% | 113.89% | -30.91% | -54.01% |
| Cash from Investing | -1,765.75% | -86.34% | 114.24% | -28.36% | -55.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -51.78% | 15,512.20% | 930.69% | -95.80% | 302.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -300.00% | 100.28% | -- |
| Cash from Financing | -51.78% | 15,542.25% | 918.63% | -95.01% | 242.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.14% | -32.10% | 148.66% | -105.81% | -225.19% |